Lupin Insists It Will Rebuild Quality Reputation Following Latest FDA Action

Indian Firm Moves On From Warning Letter As Goa Plant Gets VAI Status

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.